Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050095

Email this page to a colleague

« Back to Dashboard

NDA 050095 describes CAPASTAT SULFATE, which is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. Additional details are available on the CAPASTAT SULFATE profile page.

The generic ingredient in CAPASTAT SULFATE is capreomycin sulfate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the capreomycin sulfate profile page.
Summary for 050095
Ingredient:capreomycin sulfate
Formulation / Manufacturing:see details
Pharmacology for NDA: 050095
Medical Subject Heading (MeSH) Categories for 050095
Suppliers and Packaging for NDA: 050095
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAPASTAT SULFATE capreomycin sulfate INJECTABLE;INJECTION 050095 NDA Akorn 17478-080 17478-080-50 1 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (17478-080-50)

Profile for product number 001

Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.